Inhibitory effects of tumor necrosis factor on hematopoiesis seen in vitro are translated to increased numbers of both committed and multipotent progenitors in TNF-deficient mice

Experimental Hematology

Volumn 33, Issue 11, 2005, Pages 1348-1356

  Drutskaya, Marina S ^a   Ortiz, Mariestela ^b   Liepinsh, Dmitry J ^b   Kuprash, Dmitry V ^a   Nedospasov, Sergei A ^a,b   Keller, Jonathan R ^b  

^a ENGELHARDT INSTITUTE OF MOLECULAR BIOLOGY   (Russian Federation)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BLOOD; BONE MARROW CELL; CELL COUNT; CELL DIFFERENTIATION; CELL POPULATION; CONTROLLED STUDY; HEMATOPOIESIS; HEMATOPOIETIC SYSTEM; MOUSE; MYELOBLAST; NONHUMAN; PRIORITY JOURNAL; PROMYELOCYTE; RNA TRANSLATION; SOLUBILITY; SPLEEN; WILD TYPE;

AGE FACTORS; ANIMALS; CELL COUNT; CELL PROLIFERATION; CELLS, CULTURED; GRANULOCYTES; HEMATOPOIESIS; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HEMATOPOIETIC STEM CELLS; MICE; MICE, KNOCKOUT; MULTIPOTENT STEM CELLS; SPLEEN; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA;

EID: 27544462485     PISSN: 0301472X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.exphem.2005.08.001     Document Type: Article

References (41)

1. R. Beyaert, and W. Fiers Tumor necrosis factor and lymphotoxin A. Mire-Sluis R. Thorpe Cytokines 1998 Academic Press, Inc. San Diego 335 360
2. M. Grell, E. Douni, and H. Wajant The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 KDa tumor necrosis factor receptor Cell 83 1995 793 802
3. G. Chen, and D.V. Goeddel TNF-R1 signaling: a beautiful pathway Science 296 5573 2002 1634 1635
4. S.E. Jacobsen, F.W. Ruscetti, C.M. Dubois, and J.R. Keller Tumor necrosis factor α directly and indirectly regulates hematopoietic progenitor cell proliferation: role of colony-stimulating factor receptor modulation J Exp Med 175 6 1992 1759 1772
5. K. Abe, F.O. Yarovinsky, and T. Murakami Distinct contributions of TNF and LT cytokines to the development of dendritic cells in vitro and their recruitment in vivo Blood 101 4 2003 1477 1483
6. L.S. Rusten, E.B. Smeland, and F.W. Jacobsen Tumor necrosis factor-α inhibits stem cell factor-induced proliferation of human bone marrow progenitor cells in vitro. Role of P55 and P75 tumor necrosis factor receptors J Clin Invest 94 1 1994 165 172
7. C. Fahlman, F.W. Jacobsen, O.P. Veiby, I.K. McNiece, H.K. Blomhoff, and S.E. Jacobsen Tumor necrosis factor-α (TNF-α) potently enhances in vitro macrophage production from primitive murine hematopoietic progenitor cells in combination with stem cell factor and interleukin-7: novel stimulatory role of P55 TNF receptors Blood 84 5 1994 1528 1533
8. J.A. Rogers, and J.W. Berman TNF-α inhibits the further development of committed progenitors while stimulating multipotential progenitors in mouse long-term bone marrow cultures J Immunol 153 10 1994 4694 4703
9. C. Caux, C. Favre, and S. Saeland Potentiation of early hematopoiesis by tumor necrosis factor-α is followed by inhibition of granulopoietic differentiation and proliferation Blood 78 3 1991 635 644
10. L.S. Rusten, F.W. Jacobsen, W. Lesslauer, H. Loetscher, E.B. Smeland, and S.E. Jacobsen Bifunctional effects of tumor necrosis factor α (TNF α) on the growth of mature and primitive human hematopoietic progenitor cells: involvement of P55 and P75 TNF receptors Blood 83 11 1994 3152 3159
11. A.L. Witsell, and L.B. Schook Tumor necrosis factor α is an autocrine growth regulator during macrophage differentiation Proc Natl Acad Sci U S A 90 10 1993 4763
12. D.R. Branch, and L.J. Guilbert Autocrine regulation of macrophage proliferation by tumor necrosis factor-α Exp Hematol 24 6 1996 675 681
13. D. Bryder, V. Ramsfjell, and I. Dybedal Self-renewal of multipotent long-term repopulating hematopoietic stem cells is negatively regulated by Fas and tumor necrosis factor receptor activation J Exp Med 194 7 2001 941 952
14. J.A. Rogers, and J.W.A. Berman Tumor necrosis factor-responsive long-term-culture-initiating cell is associated with the stromal layer of mouse long-term bone marrow cultures Proc Natl Acad Sci U S A 90 12 1993 5777 5780
15. V.I. Rebel, S. Hartnett, G.R. Hill, S.B. Lazo-Kallanian, J.L. Ferrara, and C.A. Sieff Essential role for the P55 tumor necrosis factor receptor in regulating hematopoiesis at a stem cell level J Exp Med 190 10 1999 1493 1504
16. Y. Zhang, A. Harada, and H. Bluethmann Tumor necrosis factor (TNF) is a physiologic regulator of hematopoietic progenitor cells: increase of early hematopoietic progenitor cells in TNF receptor P55-deficient mice in vivo and potent inhibition of progenitor cell proliferation by TNF α in vitro Blood 86 8 1995 2930 2937
17. T. Hara, K. Ando, H. Tsurumi, and H. Moriwaki Excessive production of tumor necrosis factor-α by bone marrow T lymphocytes is essential in causing bone marrow failure in patients with aplastic anemia Eur J Haematol 73 1 2004 10 16
18. A. Bojarska-Junak, J. Rolinski, E. Wasik-Szczepaneko, Z. Kaluzny, and A. Dmoszynska Intracellular tumor necrosis factor production by T- and B-cells in B-cell chronic lymphocytic leukemia Haematologica 87 5 2002 490 499
19. C. Dufour, A. Corcione, and J. Svahn TNF-α and IFN-γ are overexpressed in the bone marrow of Fanconi anemia patients and TNF-α suppresses erythropoiesis in vitro Blood 102 6 2003 2053 2059
20. T. Mori, T. Nishimura, Y. Ikeda, T. Hotta, H. Yagita, and K. Ando Involvement of Fas-mediated apoptosis in the hematopoietic progenitor cells of graft-versus-host reaction-associated myelosuppression Blood 92 1 1998 101 107
21. G. Vinci, S. Chouaib, B. Autran, and J.P. Vernant Evidence that residual host cells surviving the conditioning regimen to allogeneic bone marrow transplantation inhibit donor hematopoiesis in vitro - the role of TNF-α Transplantation 52 3 1991 406 411
22. M. Feldmann, and R.N. Maini Anti-TNF α therapy of rheumatoid arthritis: what have we learned? Annu Rev Immunol 19 2001 163 196
23. B. Goffe Etanercept (Enbrel) - an update Skin Therapy Lett 9 10 2004 1 4 9
24. P. Mease, and B.S. Goffe Diagnosis and treatment of psoriatic arthritis J Am Acad Dermatol 52 1 2005 1 19
25. C. Antoni, G.G. Krueger, and K. de Vlam Infliximab improves signs and symptoms of psoriatic arthritis: results of the IMPACT 2 trial Ann Rheum Dis 64 8 2005 1150 1157
26. A. Kavanaugh, E.W. St Clair, W.J. McCune, T. Braakman, and P. Lipsky Chimeric anti-tumor necrosis factor-α monoclonal antibody treatment of patients with rheumatoid arthritis receiving methotrexate therapy J Rheumatol 27 4 2000 841 850
27. W.J. Sandborn New concepts in anti-tumor necrosis factor therapy for inflammatory bowel disease Rev Gastroenterol Disord 5 1 2005 10 18
28. D.E. Baker Adalimumab: human recombinant immunoglobulin G1 anti-tumor necrosis factor monoclonal antibody Rev Gastroenterol Disord 4 4 2004 196 210
29. B. Beutler Autoimmunity and apoptosis: the Crohn's connection Immunity 15 1 2001 5 14
30. H.A. Papadaki, H.D. Kritikos, and C. Gemetzi Bone marrow progenitor cell reserve and function and stromal cell function are defective in rheumatoid arthritis: evidence for a tumor necrosis factor α-mediated effect Blood 99 5 2002 1610 1619
31. S.L. Brown, M.H. Greene, S.K. Gershon, E.T. Edwards, and M.M. Braun Tumor necrosis factor antagonist therapy and lymphoma development: twenty-six cases reported to the Food and Drug Administration Arthritis Rheum 46 12 2002 3151 3158
32. F. Broussais, M. Kawashima, H. Marotte, and P. Miossec Chronic myeloid leukaemia and tuberculosis in a patient with rheumatoid arthritis treated with infliximab Ann Rheum Dis 64 3 2005 509 510
33. K. Ekstrom, H. Hjalgrim, and L. Brandt Risk of malignant lymphomas in patients with rheumatoid arthritis and in their first-degree relatives Arthritis Rheum 48 4 2003 963 970
34. M.S. Drutskaya, D.V. Kuprash, S.A. Nedospasov, I.L. Chertkov, and N.I. Drize Abnormal hemopoiesis in long-term bone marrow culture from tumor necrosis factor-deficient mice Bull Exp Biol Med 131 2 2001 150 152
35. M.A. Ershler, I.N. Nifontova, Y.V. Olshanskaya, T.V. Todria, J.L. Chertkov, and N.J. Drize Neoplastic transformation is not the cause of extremely long (more than 100 weeks) hematopoiesis maintenance of long-term bone marrow culture from TNF-deficient mice Hematol J 4 1 2003 74 77
36. T.M. Dexter, T.D. Allen, and L.G. Lajtha Conditions controlling the proliferation of haemopoietic stem cells in vitro J Cell Physiol 91 3 1977 335 344
37. C.M. Heyworth, and E. Spooncer In vitro clonal assays for murine multipotential and lineage restricted myeloid progenitor cells N.G. Testa G. Molineux Haemopoiesis a practical approach 1993 Oxford University Press New York 37 53
38. I. Dybedal, D. Bryder, A. Fossum, L.S. Rusten, and S.E. Jacobsen Tumor necrosis factor (TNF)-mediated activation of the P55 TNF receptor negatively regulates maintenance of cycling reconstituting human hematopoietic stem cells Blood 98 6 2001 1782 1791
39. D.V. Kuprash, A.V. Tumanov, and D.J. Liepinsh Novel tumor necrosis factor-knockout mice that lack Peyer's patches Eur J Immunol 35 5 2005 1592 1600
40. M.W. Marino, A. Dunn, and D. Grail Characterization of tumor necrosis factor-deficient mice Proc Natl Acad Sci U S A 94 15 1997 8093 8098
41. A. Verma, D.K. Deb, and A. Sassano Cutting edge: activation of the P38 mitogen-activated protein kinase signaling pathway mediates cytokine-induced hemopoietic suppression in aplastic anemia J Immunol 168 12 2002 5984 5988